Journals / Osteoporoz Dünyasından / 2007 / Cilt: 13 - Sayı: 4

Osteoporosis in patients with ankylosing spondylitis

Ankilozan spondilit hastalığında osteoporoz

Pages
83–87
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this paper, pathophysiology, diagnosis and treatment method of osteoporosis and vertebral fracture in patients with AS are reviewed according to the recent studies. (From the World of Osteoporosis 2007;13:83-7)

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Osteoporosis (OP) is now well recognized in patients with ankylosing spondylitis (AS).
📊
Key Findings & Data:Vertebral fractures that result from osteoporosis are a feature of longstanding AS.
💡
Conclusion & Impact:In this paper, pathophysiology, diagnosis and treatment method of osteoporosis and vertebral fracture in patients with AS are reviewed according to the recent studies. (From the World of Osteoporosis 2007;13:83-7)
🔬Design:Review & Systematic Survey
📍Scope:2007 Verileri
⚙️Variables:Omurga kırıkları · Osteoporoz · Spondilit

Abstract

Osteoporosis (OP) is now well recognized in patients with ankylosing spondylitis (AS). Vertebral fractures that result from osteoporosis are a feature of longstanding AS. In AS, diagnosis of osteoporosis is still often a challenge. Although bone density has been measured in patients with AS, the high incidence of syndesmophyte formation and ligamentous calcification makes interpretation difficult. Alternative sites such as the neck of the femur should be used for sequential assessment of bone mineral density in AS. In this paper, pathophysiology, diagnosis and treatment method of osteoporosis and vertebral fracture in patients with AS are reviewed according to the recent studies. (From the World of Osteoporosis 2007;13:83-7)

Özet

Ankilozan spondilitli (AS) hastalardaki osteoporoz (OP) iyi bilinmektedir. Uzun dönemdeki AS’nin karakteristik bir özelliği de OP sonucu olarak gelişen vertebral kırıklardır. Ankilozan spondilitteki OP’nin tanısı hala tartışmalıdır. Hastalar kemik dansitometrisi ile değerlendirilmelerine rağmen ligaman kalsifikasyonları ve sindesmofit oluşumları nedeniyle yorum yapmak güçleşmektedir. Bu yazıda, AS hastalarındaki OP ve vertebral kırığın etyopatogenezi, tanısı ve tedavisi son literatürler gözden geçirilerek sunulmuştur. (Osteoporoz Dünyasından 2007;13:83-7)

🔖

Cite This Article

TURAN, Y., DURUÖZ, M. T. (2007). Osteoporosis in patients with ankylosing spondylitis. Osteoporoz Dünyasından, Cilt: 13 - Sayı: 4, 83–87. https://ajindex.com/articles/286586

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Van der Linden. Ankylosing spondylitis. In: Kelley WN, Harris ED, Ruddy S, Sledge CB ed. Textbook of Rheumatology.Philadelphia:WB Saunders Company, 1997;969-982
  2. Braun J, Khan MA, Sieper J. Enthesitis and ankylosis in spondyloarthropathy: what is the target of the immune response? Ann Rheum Dis 2000;59:985-94
  3. Bessant R, Keat A. How should clinicians manage osteoporosis in Ankylosing Spondylitis. J Rheumatol 2002;29:1511-9
  4. Arnett FC. Ankylosing spondylitis. In:Koopman WJ, ed. Arthritis and Allied Conditions. A Textbook of Rheumatology. Baltimore,Willams and Wilkins, 1997; 1197-1208
  5. Geusens P, Vosse D, van der Heijde D, Vanhoof J, et al. High prevalence of thoracic vertebral deformities and discal wedging in ankylosing spondylitis patients with hyperkyphosis. J Rheumatol 2001;28:1856-61
  6. Lee YS, Schlotzhauer T, Ott SM, van Vollenhoven RF, et al. Skeletal Status of Men with Early and Late Ankylosing Spondylitis. Am J Med. 1997; 103: 233-241
  7. Will R, Palmer R, Bhalla AK, Ring F, et al. Osteoporosis in early ankylosing spondylitis: A primary pathological event? Lancet 1989;2:1483-5
  8. Donnelly S, Doyle DV, Denton A, Rolfe I, et al. Bone mineral density and vertebral compression fracture rates in ankylosing spondylitis. Ann Rheum Dis 1994;53:117-21
  9. Bertolini DR, Nedwin GE, Bringman TS, Smith DD, et al. Stimulation of bone resorption and inhibition of bone formation in vitro by human tumor necrosis factors. Nature 1986;319:516-8
  10. Heath JK, Saklatvala J, Meikle MC, Atkinson SJ, et al. Pig interleukin 1 (catabolin) is a potent stimulator of bone resorption in vitro. Calcif Tissue Int 1985;7:95-7
  11. Gratacós J, Collado A, Filella X, Sanmartí R, et al. Serum cytokines (IL-6, TNF-a, IL-1ß and IFN-Á) in ankylosing spondylitis: a close correlation between serum IL-6 and disease activity and severity. Br J Rheumatol 1994;33:927-31
  12. Roche NE, Fulbright JW, Wagner AD, Hunder GG, et al. Correlation of interleukin-6 production and disease activity in polymyalgia rheumatica and giant cell arteritis. Arthritis Rheum 1993;9:1286-94
  13. Lange U, Teichmann J, Stracke H. Correlation between plasma TNF-alpha, IGF-1, biochemical markers of bone metabolism, markers of inflammation/disease activity, and clinical manifestations in ankylosing spondylitis. Eur J Med Res 2000;5:507-11
  14. Demis E, Roux C, Breban M, Dougados M, et al. Infliximab in spondylarthropathy -influence on bone density. Clin Exp Rheumatol 2002;20:S185-6
  15. Woo JH, Lee HJ,